Treatment of Type 2 Diabetes with a Breakable Extended Release Gliclazide Formulation in Primary Care: The Xrise Study.

Keywords : ["breakable extended release gliclazide formulation", "xrise study", "type diabetes", "primary care", "treatment"]
Author : Fist_Author_Year_PM
31

Unique Interaction of Saroglitazar with Insulin.

Keywords : ["unique interaction", "saroglitazar", "insulin"]
Author : Fist_Author_Year_PM
111

Choice of first injectable therapy in type 2 diabetes.

Keywords : ["first injectable therapy", "type diabetes", "choice"]
Author : Fist_Author_Year_PM
31

MicroRNA-200c modulates DUSP-1 expression in diabetes-induced cardiac hypertrophy.

Keywords : ["diabetesinduced cardiac hypertrophy", "modulate expression"]
Author : Fist_Author_Year_PM
31

Thioredoxin interacting protein mediates lipid-induced impairment of glucose uptake in skeletal muscle.

Keywords : ["thioredoxin interact protein mediate lipidinduce impairment", "skeletal muscle", "glucose uptake"]
Author : Fist_Author_Year_PM
34

Performance Analysis of Fuzzy-PID Controller for Blood Glucose Regulation in Type-1 Diabetic Patients.

Keywords : ["blood glucose regulation", "performance analysis", "fuzzypid controller", "diabetic patient"]
Author : Fist_Author_Year_PM
31

Glycemic Variability and Ambulatory Glucose Profile in Indian Diabetics.

Keywords : ["ambulatory glucose profile", "indian diabetic", "glycemic variability"]
Author : Fist_Author_Year_PM
98

Hemin, a heme oxygenase-1 inducer, restores the attenuated cardioprotective effect of ischemic preconditioning in isolated diabetic rat heart.

Keywords : ["isolated diabetic rat heart", "heme inducer restore", "attenuated cardioprotective effect", "ischemic precondition", "hemin"]
Author : Fist_Author_Year_PM
31

Switching from Biphasic Human Insulin to Premix Insulin Analogs: A Review of the Evidence Regarding Quality of Life and Adherence to Medication in Type 2 Diabetes Mellitus.

Keywords : ["type diabetes mellitus", "premix insulin analog", "evidence regard quality", "biphasic human insulin", "switch", "review", "medication", "life", "adherence"]
Author : Fist_Author_Year_PM
51

Efficacy and Safety of Once-Daily Insulin Degludec/Insulin Aspart versus Insulin Glargine (U100) for 52 Weeks in Insulin-Naive Patients with Type 2 Diabetes: A Randomized Controlled Trial.

Keywords : ["oncedaily insulin degludecinsulin aspart versus insulin glargine", "randomized control trial", "type diabetes", "insulinnaive patient", "week", "safety", "efficacy"]
Author : Fist_Author_Year_PM
81